Biotie Therapies
Develops drugs focused on products for psychiatric disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
$363m (Public information from Mar 2017)
Turku Southwest Finland (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $2.0m | Grant | |
* | N/A | N/A | IPO |
$363m Valuation: $363m | Acquisition | ||
| Total Funding | $2.0m | ||
Related Content
Recent News about Biotie Therapies
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Biotie Therapies
Edit
ACQUISITION by Biotie Therapies Jan 2011
ACQUISITION by Biotie Therapies Jun 2013